The present invention relates to a pharmaceutical composition for inhibiting growth of a solid tumor of the brain in a subject, comprising a pharmaceutically acceptable diluent or carrier and a compound of formula l: (see formula I) wherein R1 is CH3, R2 is ~CH2-CH2-OH, and X is =O.